T0	Participants 102 124	chronic schizophrenia.
T1	Participants 241 281	chronic schizophrenia in-patients (n=35)
T2	Participants 341 349	Patients
T3	Participants 363 393	stable antipsychotic treatment
T4	Participants 1446 1463	chronic patients.